Katherine A. Hoadley

165.8k citations

140 papers · 8.1k indexed · 4 hit papers · h-index 41

Cancer Research top 0.2%
- Cancer Genomics and Diagnostics 47
- Breast Cancer Treatment Studies 25
Oncology top 0.5%
- HER2/EGFR in Cancer Research 17
- Cancer Immunotherapy and Biomarkers 14
Molecular Biology top 2%
- Gene expression and cancer classification 14
- RNA modifications and cancer 11
Pulmonary and Respiratory Medicine top 1%
Radiology, Nuclear Medicine and Imaging top 1%
- Radiomics and Machine Learning in Medical Imaging 10
Surgery
- Bladder and Urothelial Cancer Treatments 14

Co-authors: Charles M. Perou Joel S. Parker Huihui Fan Melissa A. Troester Jen Jen Yeh Lisa A. Carey Eric F. Lock Xiaping He
Cited by: Cancer Research Oncology Molecular Biology
Partner nations: United States Canada Spain

In The Last Decade

Katherine A. Hoadley

127 papers receiving 8.0k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2016 Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set
2016 MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays
2015 Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
2014 Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology

Peers

Countries citing papers authored by Katherine A. Hoadley

Since Specialization

Citations

This map shows the geographic impact of Katherine A. Hoadley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine A. Hoadley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine A. Hoadley more than expected).

Fields of papers citing papers by Katherine A. Hoadley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine A. Hoadley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine A. Hoadley. The network helps show where Katherine A. Hoadley may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Katherine A. Hoadley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Katherine A. Hoadley Line = papers co-authored together Katherine A. Hoadley links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prognostic and molecular multi-platform analysis of CALGB 40603 (Alliance) and public triple-negative breast cancer datasets Brooke Felsheim,Aranzazu Fernández-Martínez,Cheng Fan,Adam D. Pfefferle,Michele C. Hayward,Katherine A. Hoadley,Naim U. Rashid,Sara M. Tolaney,George Somlo,Lisa A. Carey,William M. Sikov,Charles M. Perou	2025	0
2	DAB2IP loss in luminal a breast cancer leads to NF-κB–associated aggressive oncogenic phenotypes Angana Mukherjee,Rasha T. Kakati,Sarah C. Van Alsten,Tyler Laws,Aaron Ebbs,Daniel P. Hollern,Philip M. Spanheimer,Katherine A. Hoadley,Melissa A. Troester,Jeremy M. Simon,Albert S. Baldwin	2024	1
3	Diffsig: Associating Risk Factors with Mutational Signatures Ji-Eun Park,Markia A. Smith,Sarah C. Van Alsten,Andrea Walens,Di Wu,Katherine A. Hoadley,Melissa A. Troester,Michael I. Love	2024	0
4	Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer RevealsTP53Aneuploidy–driven Metabolic Reprogramming Marni B. McClure,Yasunori Kogure,Naser Ansari‐Pour,Yuki Saito,Hann‐Hsiang Chao,Jonathan H. Shepherd,Mariko Tabata,Olufunmilayo I. Olopade,David C. Wedge,Katherine A. Hoadley,Charles M. Perou,Keisuke Kataoka	2023	11
5	Predicting early breast cancer recurrence from histopathological images in the Carolina Breast Cancer Study Yifeng Shi,Linnea T. Olsson,Katherine A. Hoadley,Benjamin C. Calhoun,J. S. Marron,Joseph Geradts,Marc Niethammer,Melissa A. Troester	2023	9
6	Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727) Holly Tovey,Orsolya Sipos,Joel S. Parker,Katherine A. Hoadley,Jelmar Quist,Sarah Kernaghan,Lucy Kilburn,Roberto Salgado,Sherene Loi,Richard D. Kennedy,Ioannis Roxanis,Patrycja Gazińska,Sarah E. Pinder,Judith M. Bliss,Charles M. Perou,Syed Haider,Anita Grigoriadis,Andrew Tutt,Maggie C.U. Cheang	2023	3
7	RNA-Based Classification of Homologous Recombination Deficiency in Racially Diverse Patients with Breast Cancer Andrea Walens,Sarah C. Van Alsten,Linnea T. Olsson,Markia A. Smith,Alex Lockhart,Xiaohua Gao,Alina M. Hamilton,Erin L. Kirk,Michael I. Love,Gaorav P. Gupta,Charles M. Perou,Cyrus Vaziri,Katherine A. Hoadley,Melissa A. Troester	2022	9
8	Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer Jeffrey S. Damrauer,Wolfgang Beckabir,Jeffrey A. Klomp,Mi Zhou,Elizabeth R. Plimack,Matthew D. Galsky,Petros Grivas,Noah M. Hahn,Peter H. O’Donnell,Gopa Iyer,David I. Quinn,Benjamin G. Vincent,Diane Zipursky Quale,Sara E. Wobker,Katherine A. Hoadley,William Y. Kim,Matthew I. Milowsky	2022	27
9	Incorporating RNA-based Risk Scores for Genomic Instability to Predict Breast Cancer Recurrence and Immunogenicity in a Diverse Population Alina M. Hamilton,Sarah C. Van Alsten,Xiaohua Gao,Joseph Nsonwu-Farley,Benjamin C. Calhoun,Michael I. Love,Melissa A. Troester,Katherine A. Hoadley	2022	4
10	Prognostic significance of RNA-based TP53 pathway function among estrogen receptor positive and negative breast cancer cases Amber N. Hurson,Mustapha Abubakar,Alina M. Hamilton,Kathleen Conway,Katherine A. Hoadley,Michael I. Love,Andrew F. Olshan,Charles M. Perou,Montserrat García‐Closas,Melissa A. Troester	2022	3
11	Genomic characterization of rare molecular subclasses of hepatocellular carcinoma Jeffrey S. Damrauer,Markia A. Smith,Vonn Walter,Aatish Thennavan,Lisle E. Mose,Sara R. Selitsky,Katherine A. Hoadley	2021	5
12	SCISSOR: a framework for identifying structural changes in RNA transcripts Hyo Young Choi,Heejoon Jo,Xiaobei Zhao,Katherine A. Hoadley,Scott Newman,Jeremiah Holt,Michele C. Hayward,Michael I. Love,J. S. Marron,D. Neil Hayes	2021	6
13	Molecular analysis of TCGA breast cancer histologic types Aatish Thennavan,Francisco Beça,Youli Xia,Susana García‐Recio,Kimberly H. Allison,Laura C. Collins,Gary M. Tse,Yunn‐Yi Chen,Stuart J. Schnitt,Katherine A. Hoadley,Andrew H. Beck,Charles M. Perou	2021	62
14	An approach for normalization and quality control for NanoString RNA expression data Arjun Bhattacharya,Alina M. Hamilton,Helena Furberg,Eugene J. Pietzak,Mark P. Purdue,Melissa A. Troester,Katherine A. Hoadley,Michael I. Love	2020	70
15	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators Jennifer L. Franks,Raquel C. Martinez‐Chacin,Xianxi Wang,Rochelle L. Tiedemann,Thomas Bonacci,Rajarshi Choudhury,Derek L. Bolhuis,Taylor P. Enrico,Ryan D. Mouery,Jeffrey S. Damrauer,Feng Yan,Joseph S. Harrison,Michael B. Major,Katherine A. Hoadley,Aussie Suzuki,Scott B. Rothbart,Nicholas G. Brown,Michael J. Emanuele	2020	9
16	Nuclear Localized LSR: A Novel Regulator of Breast Cancer Behavior and Tumorigenesis Denise K. Reaves,Katherine A. Hoadley,Katerina D. Fagan‐Solis,Dereje D. Jima,Michael S. Bereman,Lynnelle Thorpe,Jyla Hicks,David A. McDonald,Melissa A. Troester,Charles M. Perou,Jodie M. Fleming	2016	21
17	Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer Michael D. Iglesia,Benjamin G. Vincent,Joel S. Parker,Katherine A. Hoadley,Lisa A. Carey,Charles M. Perou,Jonathan S. Serody	2014	194
18	Impact of Tumor Microenvironment and Epithelial Phenotypes on Metabolism in Breast Cancer Heather Ann Brauer,Liza Makowski,Katherine A. Hoadley,Patricia Casbas-Hernández,Lindsay J. Lang,Erick Romàn-Pèrez,Monica D’Arcy,Alex J. Freemerman,Charles M. Perou,Melissa A. Troester	2012	78
19	Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types Matthew D. Wilkerson,Xiaoying Yin,Katherine A. Hoadley,Yufeng Liu,Michele C. Hayward,Christopher R. Cabanski,Kenneth L. Muldrew,C. Ryan Miller,Scott H. Randell,Mark A. Socinski,Alden M. Parsons,William K. Funkhouser,Carrie B. Lee,Patrick J. Roberts,Leigh B. Thorne,Philip S. Bernard,Charles M. Perou,D. Neil Hayes	2010	194
20	Cell-Type-Specific Responses to Chemotherapeutics in Breast Cancer Melissa A. Troester,Katherine A. Hoadley,Thérese Sørlie,Brittney‐Shea Herbert,Anne‐Lise Børresen‐Dale,Per Eystein Lønning,Jerry W. Shay,William K. Kaufmann,Charles M. Perou	2004	143

About Katherine A. Hoadley

Katherine A. Hoadley is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 140 papers that have together received 8.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (47 papers), Breast Cancer Treatment Studies (25 papers), HER2/EGFR in Cancer Research (17 papers), Gene expression and cancer classification (14 papers), Bladder and Urothelial Cancer Treatments (14 papers), Cancer Immunotherapy and Biomarkers (14 papers), RNA modifications and cancer (11 papers) and Radiomics and Machine Learning in Medical Imaging (10 papers). The work is most often cited by research in Cancer Research (3.0k citations), Oncology (3.8k citations) and Molecular Biology (3.5k citations). Katherine A. Hoadley has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Charles M. Perou, Joel S. Parker, Huihui Fan, Melissa A. Troester, Jen Jen Yeh, Lisa A. Carey, Eric F. Lock, Xiaping He, J. S. Marron and Andrew B. Nobel.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact